Ipsos MMA is a leader in helping pharma and healthcare brands measure and optimize the value of their patient and HCP promotions. Ipsos MMA’s Unified Patient & HCP Attribution model has been validated with clients and shown to produce measurable improvements in revenue and profits. Ipsos MMA has also been named a leader in The Forrester Wave™ : Marketing Measurement & Optimization Solutions.
Ipsos MMA is a leading analytics consultancy founded in 1989. The company enables its clients to achieve higher revenues and operating profits via their forward-looking, data-driven analytics, software and consulting solutions. Ipsos MMA is headquartered in New York, and part of the leading global custom market research company Ipsos.
Learn more about Ipsos MMA
The partnership between Ipsos MMA and HealthVerity enables pharma brands to measure the impact of investment across patient and physician journeys. It delivers privacy-protected and HIPAA-compliant activations with media platforms for pharmaceutical brands as an end-to-end, closed-loop measurement and optimization solution.
This innovative and future-proofed capability enables pharmaceutical marketers to generate and activate audiences, measure the quality of the audiences reached and optimize omnichannel net conversion lift while campaigns are in market. Through a combination of privacy-protected, HIPAA-compliant data, processes and advanced AI modeling, brands can now automate “next best actions” across patient and physician journeys to drive incremental scripts and adherence, maximizing long-term profits.